A detailed history of Anchor Investment Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Anchor Investment Management, LLC holds 143,303 shares of PFE stock, worth $3.83 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
143,303
Previous 145,162 1.28%
Holding current value
$3.83 Million
Previous $4.03 Billion 0.46%
% of portfolio
0.41%
Previous 0.42%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 20, 2024

SELL
$25.26 - $29.6 $46,958 - $55,026
-1,859 Reduced 1.28%
143,303 $4.01 Billion
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $93,877 - $107,800
-3,626 Reduced 2.44%
145,162 $4.03 Billion
Q4 2023

Jan 02, 2024

BUY
$26.13 - $33.94 $3.89 Million - $5.05 Million
148,788 New
148,788 $4.28 Billion
Q3 2023

Jan 02, 2024

SELL
$32.09 - $37.51 $102,816 - $120,182
-3,204 Reduced 2.0%
157,020 $5.21 Billion
Q2 2023

Jan 02, 2024

BUY
$36.12 - $41.79 $15,965 - $18,471
442 Added 0.28%
160,224 $5.88 Billion
Q1 2023

Jan 02, 2024

SELL
$39.39 - $51.28 $77,519 - $100,919
-1,968 Reduced 1.22%
159,782 $6.52 Billion
Q4 2022

Jan 02, 2024

BUY
$41.75 - $54.5 $541,163 - $706,429
12,962 Added 8.71%
161,750 $8.29 Billion
Q3 2022

Jan 02, 2024

BUY
$43.76 - $53.42 $493,875 - $602,898
11,286 Added 7.59%
160,074 $7 Billion
Q2 2022

Jan 02, 2024

SELL
$46.53 - $55.17 $17,076 - $20,247
-367 Reduced 0.23%
157,228 $8.24 Billion
Q1 2022

Jan 02, 2024

SELL
$45.75 - $56.69 $42,044 - $52,098
-919 Reduced 0.58%
157,595 $8.16 Billion
Q4 2021

Jan 02, 2024

BUY
$41.32 - $61.25 $259,778 - $385,078
6,287 Added 4.13%
158,514 $9.36 Billion
Q3 2021

Jan 02, 2024

BUY
$39.25 - $50.42 $134,980 - $173,394
3,439 Added 2.31%
152,227 $6.55 Billion
Q2 2021

Jan 02, 2024

BUY
$35.91 - $40.68 $93,581 - $106,012
2,606 Added 1.79%
148,436 $5.81 Billion
Q1 2021

Jan 02, 2024

BUY
$33.49 - $37.77 $429,710 - $484,626
12,831 Added 9.65%
145,830 $5.28 Billion
Q4 2020

Jan 02, 2024

BUY
$33.47 - $42.56 $220,734 - $280,683
6,595 Added 5.22%
132,999 $4.9 Billion
Q3 2020

Jan 02, 2024

SELL
$31.75 - $37.25 $710,692 - $833,804
-22,384 Reduced 15.04%
126,404 $4.64 Billion
Q2 2020

Jan 02, 2024

BUY
$30.12 - $36.54 $2,560 - $3,105
85 Added 0.07%
124,222 $4.06 Billion
Q1 2020

Jan 02, 2024

BUY
$27.03 - $38.62 $183,533 - $262,229
6,790 Added 5.79%
124,137 $4.05 Billion
Q4 2019

Jan 02, 2024

BUY
$32.92 - $37.36 $643,421 - $730,201
19,545 Added 19.98%
117,347 $4.6 Billion
Q3 2019

Jan 02, 2024

SELL
$32.49 - $42.13 $1.66 Million - $2.15 Million
-50,986 Reduced 34.27%
97,802 $3.51 Billion
Q2 2019

Jan 02, 2024

BUY
$36.98 - $41.52 $147,143 - $165,208
3,979 Added 4.35%
95,451 $4.13 Billion
Q1 2019

Jan 02, 2024

SELL
$37.5 - $41.2 $20,362 - $22,371
-543 Reduced 0.59%
91,472 $3.88 Billion
Q4 2018

Jan 02, 2024

BUY
$38.47 - $43.86 $14,464 - $16,491
376 Added 0.41%
92,015 $4.02 Billion
Q3 2018

Jan 02, 2024

SELL
$34.47 - $41.81 $1.97 Million - $2.39 Million
-57,149 Reduced 38.41%
91,639 $4.04 Billion
Q2 2018

Jan 03, 2024

SELL
$32.98 - $35.16 $1.86 Million - $1.98 Million
-56,250 Reduced 37.81%
92,538 $3.36 Billion
Q1 2018

Jan 03, 2024

BUY
$31.91 - $37.02 $95,123 - $110,356
2,981 Added 3.39%
91,040 $3.23 Billion
Q4 2017

Jan 03, 2024

BUY
$33.26 - $35.29 $50,521 - $53,605
1,519 Added 1.76%
88,059 $3.19 Billion
Q3 2017

Jan 03, 2024

BUY
$31.0 - $34.15 $51,212 - $56,415
1,652 Added 1.95%
86,540 $3.09 Billion
Q2 2017

Jan 03, 2024

SELL
N/A
-63,900 Reduced 42.95%
84,888 $2.85 Billion
Q1 2017

Jan 03, 2024

BUY
N/A
2,570 Added 3.23%
82,169 $2.81 Billion
Q4 2016

Jan 03, 2024

BUY
N/A
1,820 Added 2.34%
79,599 $2.59 Billion
Q3 2016

Jan 03, 2024

BUY
N/A
284 Added 0.37%
77,779 $2.63 Billion
Q2 2016

Jan 03, 2024

SELL
N/A
-71,293 Reduced 47.92%
77,495 $2.73 Billion
Q1 2016

Jan 03, 2024

SELL
N/A
-73,035
75,753 $2.25 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.